United Guardian (UG) Cash & Current Investments (2010 - 2026)
United Guardian's (UG) quarterly Cash & Current Investments came in at $9.6 million in Q2 2026, up 13.93% year-over-year from $8.4 million in Q2 2025, and up 19.38% quarter-over-quarter from $8.0 million in Q1 2026.
Analysis
United Guardian (UG) Cash & Current Investments (2010 - 2026) Analysis & Trends
United Guardian has disclosed Cash & Current Investments across 17 years of filings, most recently posting $9.6 million for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 13.93% year-over-year to $9.6 million; the TTM figure through Jun 2026 stood at $9.6 million (up 13.93% YoY), while the FY2025 annual figure was $8.6 million, down 8.77% from the prior year.
- Cash & Current Investments came in at $9.6 million for Q2 2026 at United Guardian, up from $8.0 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $15.5 million in Q2 2024 to a low of $6.5 million in Q4 2022.
- Average Cash & Current Investments over 5 years is $9.6 million, with a median of $8.5 million recorded in 2025.
- Year-over-year, Cash & Current Investments soared 131.18% in 2023 and tumbled 45.5% in 2025.
- Over 5 years, Cash & Current Investments stood at $6.5 million in 2022, then soared by 131.18% to $15.0 million in 2023, then sank by 37.3% to $9.4 million in 2024, then retreated by 8.77% to $8.6 million in 2025, then climbed by 11.9% to $9.6 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $9.6 million in Q2 2026, $8.0 million in Q1 2026, and $8.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.34 Bn | 625.58 Bn | 17.26 Bn | 20.76 Bn |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 366.20 Bn | 359.06 Bn | 12.21 Bn | 7.14 Bn |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 7.69 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 11.70 Bn |
| 6 | Sanofi | 52.41 Bn | 45.03 Bn | 10.79 Bn | 7.38 Bn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 8 | Incyte | 25.52 Bn | 20.98 Bn | 1.57 Bn | 4.54 Bn |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn | 2.66 Bn |
| 10 | United Guardian | 32.46 Mn | 22.87 Mn | 1.55 Mn | 9.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.59 Mn |
| Mar 31, 2026 | 8.04 Mn |
| Dec 31, 2025 | 8.57 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Jun 30, 2025 | 8.42 Mn |
| Mar 31, 2025 | 8.12 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 15.45 Mn |
| Mar 31, 2024 | 13.31 Mn |
| Dec 31, 2023 | 14.99 Mn |
| Sep 30, 2023 | 12.82 Mn |
| Jun 30, 2023 | 11.15 Mn |
| Mar 31, 2023 | 6.97 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 7.15 Mn |
| Jun 30, 2022 | 6.77 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 8.17 Mn |
| Sep 30, 2021 | 9.59 Mn |